Location History:
- Kensington, MD (US) (2006)
- Bethesda, MD (US) (2011)
Company Filing History:
Years Active: 2006-2011
Title: Innovations by Diane E Breckenridge
Introduction
Diane E Breckenridge is a notable inventor based in Bethesda, MD (US). She has made significant contributions to the field of biomedical research, particularly in the areas of cell motility and angiogenesis. With a total of 2 patents, her work focuses on developing methods to inhibit cancer progression.
Latest Patents
Breckenridge's latest patents include innovative methods for inhibiting cell motility and angiogenesis. One patent discloses methods of inhibiting cell motility by targeting the binding between an intracellular transducer and a receptor protein tyrosine kinase. This method specifically addresses hepatocyte growth factor (HGF) induced cell motility. Additionally, it provides a means to inhibit angiogenesis using peptides such as phosphotyrosyl mimetics. Another patent outlines similar methods for preventing and treating diseases like metastatic cancer, including melanoma and prostate cancer, by administering specific peptides. These inventions also include techniques for blocking HGF, VEGF, or bFGF-stimulated migration, cell proliferation, and the formation of capillary-like structures.
Career Highlights
Diane E Breckenridge is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this prestigious institution has allowed her to contribute to groundbreaking research in cancer treatment and prevention.
Collaborations
Breckenridge has collaborated with esteemed colleagues such as Donald P Bottaro and Safiye N Atabey. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Diane E Breckenridge's contributions to the field of biomedical research are significant and impactful. Her innovative patents and collaborations reflect her dedication to advancing cancer treatment methodologies.